Fred Hutchinson Cancer Center CEO salary and executive pay
Fred Hutchinson Cancer Center paid its CEO, Thomas J Lynch MD, $2,598,413 for the fiscal year ending June 2025. That is up $206,200 (8.6%) from the fiscal year ending June 2024. Total revenue on that return was $2,532,392,907, up 24.9% from $2,027,046,671 for the fiscal year ending June 2024. Fred Hutchinson Cancer Center ranks 139th of 229 hospital systems on this site by CEO pay. Fred Hutchinson Cancer Center has 4 Form 990 returns on record, for fiscal years ending 2022 to 2025.
Last updated from IRS e-file data. EIN 91-1935159, Seatle, WA.
CEO, fiscal year ending June 2025
$2,598,413
- Total revenue
- $2,532,392,907
- CEO pay vs. peers
- Higher than 30%
Source: Form 990, fiscal year ending June 2025, IRS object ID 202621359349315427.View the filing
Peers: the 183 other hospital systems on this site. Ranked 128th of 184 by top pay as a share of revenue. Pay is 0.10% of revenue, our calculation from the same return. Revenue is Part I, line 12; peers are compared on their latest full-year returns.
Highest-paid people on the latest return
On the latest return, 18 people were paid more than $500,000, 9 of them more than $1 million.
| Name and title | Total |
|---|---|
| Thomas J Lynch MD CEO President & Director | $2,598,413 |
| Nicole C Robinson PhDVP & Chief Operating Officer | $1,755,535 |
| Sara Hurvitz MDSVP & Director, Clinical Research | $1,468,766 |
| Nancy Davidson MDEVP, Clinical Affairs | $1,424,165 |
| David BrowdyVP & Chief Financial Officer | $1,357,937 |
Also paid on the latest return: Tom Purcell MD (VP & Chief Medical Officer), $1,304,414; Bruce E Clurman MD PhD (EVP, Chief Sci. Officer & Deputy Director), $1,180,892; Steven Haydon (Former Officer), $1,059,753; Eric C Holland MD PhD (SVP & Director, Human Biology), $1,009,846; Nida Shekhani (VP & Chief Strategy Officer), $965,527; Frederick Appelbaum MD (Executive Vice President), $958,897; Kelly O'Brien (VP & Chief Philanthropy Officer), $934,006; Geoffrey Hill MD (SVP & Director, Translational Sci), $916,834; Warren T Phipps MD (Associate Professor), $804,526; Jodi Burke (VP, Human Resources), $758,188; Gerianne Sands (Corporate Secretary, VP & General Counsel), $642,019; Stephanie Mays (Former Officer), $532,884; Denene Prophet-Williams MBA MLA BSN (VP & Chief Nursing Officer - Beg 4/1/24), $530,352; Brittany McCreery MD (Former Key Employee), $485,712; Richard Lafrance (Former Key Employee), $400,565; and 12 more.
Also listed in Part VII of the latest return, with no pay reported: Julie Nordstrom (Secretary), Leigh Morgan (Chair), Pete Shimer (Treasurer), Richard Anderson (Vice-Chair), Bradley Simmons (Director), Cheryl M Scott (Director), Eduardao Penalver (Director), James Lico (Director - Beg 6/18/25), Jeff Yurcisin (DIRECTOR - Beg 1/29/25), Joanne Harrell (Director), Kathy Surace-Smith (Director), Michelle Seitz (Director), Sean Boyle (Director), Stephen Graham (Director), Timothy H Dellit MD (Director).
CEO pay by year
Each row is the CEO on that year's return.
| Fiscal year ending | Name and title | Total | Revenue | Source |
|---|---|---|---|---|
| Jun 2025 | Thomas J Lynch MD CEO President & Director | $2,598,413 | $2,532,392,907 | Filing |
| Jun 2024 | Thomas J Lynch MD CEO PRESIDENT & DIRECTOR | $2,392,213 | $2,027,046,671 | Filing |
| Jun 2023 | Thomas Lynch CEO PRESIDENT & DIRECTOR | $1,963,020 | $2,322,795,971 | Filing |
| Jun 2022 | Thomas Lynch CEO PRESIDENT & DIRECTOR | $0 | $1,283,961,922 | Filing |
How this pay was reported
The parts of each total, as reported on the return for the fiscal year ending June 2025.
Source: Form 990, fiscal year ending June 2025, IRS object ID 202621359349315427.View the filing
| Part VII | Schedule J | |||||||
|---|---|---|---|---|---|---|---|---|
| Name and title | From org | Other | Base | Bonus | Other | Deferred | Nontaxable | Total |
| Thomas J Lynch MDPresident & Director | $2,232,376 | $366,037 | $1,867,885 | $333,967 | $30,524 | $328,275 | $37,762 | $2,598,413 |
| Nicole C Robinson PhDVP & Chief Operating Officer | $1,587,507 | $168,028 | $913,033 | $649,764 | $24,710 | $142,375 | $25,653 | $1,755,535 |
| Sara Hurvitz MDSVP & Director, Clinical Research | $1,271,572 | $197,194 | $1,149,456 | $85,994 | $36,122 | $160,425 | $36,769 | $1,468,766 |
| Nancy Davidson MDEVP, Clinical Affairs | $1,250,784 | $173,381 | $1,053,059 | $181,992 | $15,733 | $147,286 | $26,095 | $1,424,165 |
| David BrowdyVP & Chief Financial Officer | $1,186,790 | $171,147 | $916,534 | $262,732 | $7,524 | $138,585 | $32,562 | $1,357,937 |
These figures come from Fred Hutchinson Cancer Center's Form 990 returns, as the IRS publishes them. The methodology page explains how they're chosen. To report an error, email corrections@ceopaycheck.com.
How Fred Hutchinson Cancer Center compares
Ranked 139th of 229 hospital systems by CEO pay.
- Previous in this ranking: 138th, Memorial Health (Illinois), $2,607,083
- Next in this ranking: 140th, Nicklaus Children's Health System, $2,570,950
Closest in revenue among the hospital systems on this site:
Methodist Health System (Dallas)$4,078,719 (CEO), fiscal year ending Sep 2025
Cooper University Health Care$3,398,140 (CEO), fiscal year ending Dec 2024
UVM Medical Center$2,235,745 (CEO), fiscal year ending Sep 2025
West Virginia University Hospitals (WVU Medicine)$1,145,956 (CEO), fiscal year ending Dec 2024
WakeMed$2,218,512 (CEO), fiscal year ending Sep 2025
Common questions
Thomas J Lynch MD (President & Director) was paid $2,598,413 for the fiscal year ending June 2025: $2,232,376 from Fred Hutchinson Cancer Center and $366,037 in other compensation (Part VII columns D and F).
The CEO, Thomas J Lynch MD, was the highest-paid person on the latest return, at $2,598,413.
Fred Hutchinson Cancer Center paid its CEO, Thomas J Lynch MD, $2,598,413 for the fiscal year ending June 2025. That is up $206,200 (8.6%) from the fiscal year ending June 2024. The earliest return on record is for the fiscal year ending June 2023, when the CEO was Thomas Lynch, paid $1,963,020. By fiscal year end: June 2022, $0 (Thomas Lynch); June 2023, $1,963,020; June 2024, $2,392,213; June 2025, $2,598,413.
Fred Hutchinson Cancer Center's return for the fiscal year ending June 2025 reports total expenses of $2,405,985,717 and total revenue of $2,532,392,907 (Part I, lines 18 and 12), so revenue exceeded expenses by $126,407,190. Expenses were $2,064,743,953 for the fiscal year ending June 2024, so they rose 16.5%. The CEO's pay of $2,598,413 equals 0.11% of expenses, our calculation.
From the 4 Form 990 returns Fred Hutchinson Cancer Center filed with the IRS for fiscal years ending 2022 to 2025. The latest full-year return was filed on May 15, 2026. Schedule J of the fiscal year ending June 2025 return breaks down pay for all 5 people in the pay breakdown above.